Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients

Yu Chih Shen*, Shih Fen Chen, Chia Hsiang Chen, Chaucer C.H. Lin, Shaw Ji Chen, Yu Jung Chen, Sy Ueng Luu

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

50 Scopus citations


Objectives: Aripiprazole, a novel antipsychotic agent, acts as a partial agonist at dopamine D2 receptors (DRD2). We investigate whether its efficacy is predictable by DRD2/ANKK1 gene polymorphisms and clinical factors in Han Chinese hospitalized patients with acutely exacerbated schizophrenia. Method: After hospitalization, the patients (n = 128) were given aripiprazole for up to 4 weeks. They were genotyped for four functional DRD2/ANKK1 polymorphisms: -141 Ins/Del, Ser311Cys, C957T, and TaqIA. Clinical factors such as gender, age, illness duration, education level, diagnostic subtype, and medication dosage were also recorded. Psychopathology was measured biweekly with the positive and negative syndrome scale (PANSS). The effects of genetic and clinical factors on PANSS performance upon aripiprazole treatment were analyzed by a mixed modeling approach (SAS Proc MIXED). Results: Compared to the patients with TaqI A2/A2 genotype, A1 carriers are associated with superior therapeutic response on positive symptoms after 4-week aripiprazole treatment. Regarding the C957T polymorphism, patients with C/C genotype were associated with poor aripiprazole response for excitement symptoms when compared with T/T patients. The other two polymorphisms, -141 Ins/Del, and Ser311Cys, have no significant effects on PANSS performance. The clinical factors including medication dosage, illness duration, and diagnostic subtype could influence PANSS performance upon aripiprazole treatment. Conclusion: This study suggests that DRD2/ANKK1 gene variations and some clinical factors may predict individual response to aripiprazole.

Original languageEnglish
Pages (from-to)600-606
Number of pages7
JournalJournal of Psychiatric Research
Issue number6
StatePublished - 03 2009
Externally publishedYes


  • -141 Ins/Del
  • Aripiprazole
  • C957T
  • DRD2/ANKK1
  • Ser311Cys
  • TaqIA


Dive into the research topics of 'Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients'. Together they form a unique fingerprint.

Cite this